Ameritas Investment Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-17,513
| Closed | -$2.89M | – | 3114 |
|
|
2021
Q2 | $2.89M | Sell |
17,513
-216
| -1% | -$36.1K | 0.1% | 195 |
|
|
2021
Q1 | $2.72M | Hold |
17,729
| – | – | 0.1% | 206 |
|
|
2020
Q4 | $2.22M | Sell |
17,729
-379
| -2% | -$42.4K | 0.1% | 238 |
|
|
2020
Q3 | $1.84M | Sell |
18,108
-298
| -2% | -$30.4K | 0.08% | 252 |
|
|
2020
Q2 | $1.79M | Buy |
18,406
+657
| +4% | +$61.1K | 0.09% | 238 |
|
|
2020
Q1 | $1.47M | Hold |
17,749
| – | – | 0.08% | 250 |
|
|
2019
Q4 | $1.97M | Hold |
17,749
| – | – | 0.09% | 252 |
|
|
2019
Q3 | $1.76M | Buy |
17,749
+489
| +3% | +$48.6K | 0.08% | 276 |
|
|
2019
Q2 | $1.71M | Hold |
17,260
| – | – | 0.08% | 285 |
|
|
2019
Q1 | $1.9M | Buy |
17,260
+160
| +0.9% | +$16.7K | 0.09% | 254 |
|
|
2018
Q4 | $1.57M | Hold |
17,100
| – | – | 0.09% | 272 |
|
|
2018
Q3 | $1.88M | Buy |
17,100
+2,200
| +15% | +$229K | 0.09% | 269 |
|
|
2018
Q2 | $1.39M | Buy |
14,900
+10,696
| +254% | +$921K | 0.07% | 380 |
|
|
2018
Q1 | $349K | Hold |
4,204
| – | – | 0.02% | 837 |
|
|
2017
Q4 | $383K | Hold |
4,204
| – | – | 0.02% | 803 |
|
|
2017
Q3 | $325K | Buy |
4,204
+800
| +24% | +$60.5K | 0.02% | 863 |
|
|
2017
Q2 | $255K | Buy |
3,404
+1,315
| +63% | +$91.2K | 0.01% | 929 |
|
|
2017
Q1 | $136K | Buy |
+2,089
| New | +$123K | 0.01% | 1256 |
|
Other funds holding PRAH
Ameritas Investment Partners's PRAH Position: Q3 2021 in Review
Ameritas Investment Partners sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 17,513 shares — an estimated $2.89M sold.
Ameritas Investment Partners first reported a position in PRAH in Q1 2017 and held it in 18 quarters. The position peaked at $2.89M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Ameritas Investment Partners reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Ameritas Investment Partners sold 17,513 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $2.89M.
- Ameritas Investment Partners first reported a position in PRA Health Sciences, Inc. in Q1 2017 and held it in 18 quarters.
- Ameritas Investment Partners's PRA Health Sciences, Inc. position peaked at $2.89M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Ameritas Investment Partners's 13F filing for Q3 2021, filed 15 Nov 2021.